Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
Titel:
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
Auteur:
Penn-Nicholson, Adam Tameris, Michele Smit, Erica Day, Tracey A Musvosvi, Munyaradzi Jayashankar, Lakshmi Vergara, Julie Mabwe, Simbarashe Bilek, Nicole Geldenhuys, Hendrik Luabeya, Angelique Kany-Kany Ellis, Ruth Ginsberg, Ann M Hanekom, Willem A Reed, Steven G Coler, Rhea N Scriba, Thomas J Hatherill, Mark